Search for: "Manning v. Pfizer, Inc"
Results 21 - 34
of 34
Sorted by Relevance
|
Sort by Date
6 Jul 2023, 6:11 am
Prometheus Labs., Inc., 132 S. [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
17 Mar 2009, 12:50 pm
This warning procedure was outlined in Est’ee Lauder, Inc. v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
27 Feb 2014, 6:00 am
We know from Guenther v. [read post]
4 Apr 2008, 1:00 am
: (IPBiz), One example of when taking a license makes sense: (Anything Under the Sun Made by Man), New national-level programmes echo WIPO patent treaty: (Intellectual Property Watch), Office Open XML officially approved as international standard: (IP Watch), (Ars Technica), Free, worldwide patent search site – PriorSmart.com: (The Invent Blog) Global - Copyright Fordham IP law & policy conference: (Orphan works legislation in the US and around the… [read post]
17 Mar 2020, 1:32 pm
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
5 Sep 2008, 11:01 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Google Chrome EULA – Controversy over non-exclusive license clause permitting Google to use content submitted through the service: (IP Thinktank), (BriefBlog), (Copyfight), (Copyfight), (The Trademark Blog), (Public Knowledge), (Ars Technica), (IPKat), US presidential campaigns clash on patent law: (Out-Law), (IAM), (Anything Under the… [read post]
20 Jul 2011, 1:27 pm
Pfizer, Inc., 773 N.E.2d 720 (Ill. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
2 Aug 2014, 6:05 am
Niven v. [read post]
28 Nov 2011, 4:02 am
Courts have precluded the use of class actions against drug makers in most cases (see, e.g., Valentino v. [read post]
2 Apr 2012, 6:15 am
(In case you’re wondering, the remaining five are Microsoft, Pfizer, Exxon-Mobil, Johnson & Johnson and ADP.) [read post]
